Benzinga's Top #PreMarket Gainers

By: via Benzinga
Juno Therapeutics Inc (NASDAQ: JUNO) shares climbed 35.59 percent to $62.78 in pre-market trading on news that it signed a 10-year ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.